The software provider recently led Medcast's $4 million capital raise to expand its AI-enabled clinical knowledge platform.

Francisco Partners led the Series E round, which will support the company’s AI capabilities and pharmacy benefits platform.

The integration connects wearable health trends with Xella Health's diagnostic testing and physician-guided treatment.

The Series D brings the company’s total capital raised to $430 million as it expands its clinical program, pursues further ...

The American Medical Association's Jennifer Goldsack says physicians, technology experts, policymakers and patients must all work together to leverage AI and digital tools to make care more accessible ...

A participant in Neuralink’s experimental VOICE study used the company’s brain-computer interface to generate speech in a ...

AI drug discovery and development company Iambic Therapeutics has filed for an initial public offering, according to a ...

The acquisition expands Hello Patient’s automation platform from patient communications to back-office tasks such as ...

Trained on MRI and ultrasound datasets, the AI framework correctly classified cases 83% of the time in early testing and ...

Previous work in Auckland's Middlemore Hospital saw rostering time reduced to less than 20 hours per month from 120 hours per ...

Life sciences organizations can apply to use the model with fewer safety guardrails for biology research through the ...

Dr. Matthew Meyer, University of Virginia sustainable healthcare expert, says hospitals can reduce nitrous oxide and desflurane emissions without compromising patient care.